Reconsidering the safety of over-the-counter decongestants

Annals of Emergency Medicine

Volumn 45, Issue 2, 2005, Pages 217-218

  Caravati, E Martin ^a,b  

^a Utah Poison Control Center   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECONGESTIVE AGENT; ERYTHROMYCIN; IBUPROFEN; KETOCONAZOLE; NON PRESCRIPTION DRUG; PARACETAMOL; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; TERFENADINE;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; COLITIS; DRUG SAFETY; EDITORIAL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; PRIORITY JOURNAL; STROKE; VASOSPASM;

DRUGS, NON-PRESCRIPTION; EPHEDRINE; HUMANS; NASAL DECONGESTANTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 12444314998     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2004.08.037     Document Type: Editorial

References (18)

1. J. Lazarou, B.H. Pomeranz, and P.N. Corey Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies JAMA 279 1998 1200 1205
2. A.F. Manini, C. Kabrhel, and T.W. Thomsen Acute myocardial infarction after over-the-counter use of pseudoephedrine Ann Emerg Med 45 2005 213 216
3. M. Meadows FDA issues public health advisory on phenylpropanolamine in drug products FDA Consum 35 2001 9
4. W.N. Kernan, C.M. Viscoli, and L.M. Brass Phenylpropanolamine and the risk of hemorrhagic stroke N Engl J Med 343 2000 1826 1832
5. C.A. Haller, and N.L. Benowitz Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids N Engl J Med 343 2000 1833 1838
6. D.W. Kaufman, J.P. Kelly, and L. Rosenberg Recent patterns of medication use in the ambulatory adult population of the United States JAMA 287 2002 337 344
7. M. Porta, H. Jick, and J.A. Habakangas Follow-up study of pseudoephedrine users Ann Allergy 57 1986 340 342
8. R.A. Rosen Angina associated with pseudoephedrine Ann Emerg Med 10 1981 230 231
9. S. Wright, and A. Tomassoni Acute myocardial infarction following therapeutic use of pseudoephedrine [abstract] Vet Hum Toxicol 36 1994 366
10. H. Derreza, M.D. Fine, and A. Sadaniantz Acute myocardial infarction after use of pseudoephedrine for sinus congestion J Am Board Fam Pract 10 1997 436 438
11. G. Grzesk, G. Polak, and Z. Grabczewska Myocardial infarction with normal coronary arteriogram: the role of ephedrine-like alkaloids Med Sci Monit 10 2004 CS15 CS21
12. K.J. Pederson, D.H. Kuntz, and G.J. Garbe Acute myocardial ischemia associated with ingestion of bupropion and pseudoephedrine in a 21-year-old man Can J Cardiol 17 2001 599 601
13. I. Wiener, A.G. Tilkian, and M. Palazzolo Coronary artery spasm and myocardial infarction in a patient with normal coronary arteries: temporal relationship to pseudoephedrine ingestion Cathet Cardiovasc Diagn 20 1990 51 53
14. C. Cantu, A. Arauz, and L.M. Murillo-Bonilla Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs Stroke 34 2003 1667 1673
15. J. Dowd, D. Bailey, and K. Moussa Ischemic colitis associated with pseudoephedrine: four cases Am J Gastroenterol 94 1999 2430 2434
16. A.J. Wood, C.M. Stein, and R. Woosley Making medicines safer - the need for an independent drug safety board N Engl J Med 339 1998 1851 1854
17. D.A. Kessler Introducing MedWatch: a new approach to reporting medication and device adverse effects and product problems JAMA 269 1993 2765 2768
18. P.K. Honig, D.C. Wortham, and K. Zamani Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences JAMA 269 1993 1513 1550